|
|
| Research article summary (published 30 Aug 2009): |
Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
Full Abstract
PURPOSE OF REVIEW: To describe the results of two recent prospective studies that may indicate how to monitor, diagnose, and treat fetuses with neonatal lupus manifesting with heart involvement and to summarize additional research reports regarding the pathophysiology and outcomes of this rare condition. RECENT FINDINGS: The PR Interval and Dexamethasone Evaluation study found 10 cases of neonatal lupus (10%) with three first-degree atrioventricular blocks (AVBs) and three complete heart blocks. The study included 98 pregnancies in 95 women with anti-SSA/Ro antibodies who completed weekly fetal Doppler echocardiogram-based evaluation. The authors concluded that they were unable to detect first-degree AVB before progression to complete heart block. A similar observational prospective study was performed in 70 fetuses of 56 mothers using tissue velocity fetal kinetocardiogram for measurement of PR prolongation. In this study, six fetuses (8.5%) showed first-degree AVB, and fast normalization of heart function was achieved through maternal treatment with fluorinated steroids. The authors concluded that fetal kinetocardiogram can detect first-degree AVB in the fetus exposed to maternal anti-SSA/Ro or anti-SSB/La antibodies or both and that fluorinated steroids given on detection were associated with normalized atrioventricular conduction in fetuses with first-degree AVB. SUMMARY: Echo Doppler seems a less reliable method for early detection of fetus first-degree AVB, and it is suggested that fetal kinetocardiogram or fetal electrocardiography are preferred. Although atrioventricular block reverses spontaneously in some fetuses, parents and treating physicians should consider immediate treatment with fluorinated steroids once a first-degree AVB is detected due to the high risk of rapid progression to complete blockage.
Author information
Author/s: Mevorach, Dror (D); Elchalal, Uriel (U); Rein, Azaria J J T (AJ);
Affiliation: Rheumatology Research Center, Hadassah-Hebrew University Medical Center, Kiryat Hadassah, Jerusalem, Israel. mevorachd(-atsign-)hadassah.org.il
Journal and publication information
Publication Type: Journal Article; Review
Journal: Current opinion in rheumatology (Curr Opin Rheumatol), published in United States. (Language: eng)
Reference: 2009-Sep; vol 21 (issue 5) : pp 478-82
Dates: Created 2009/08/13; Completed 2009/11/04;
PMID: 19584727, status: MEDLINE (last retrieval date: 11/4/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjögren's syndrome.
30 Dec 2006 - Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al.
30 Dec 2002 - Predicting autoimmune congenital heart block: is it feasible and how?
8 Jul 2007 - [Neonatal lupus erythematosus: dermatitis, A-V block and SSA/Ro antibodies]
30 Jul 1992 - Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study.
30 Dec 2001 - A serologic marker for fetal risk of congenital heart block.
29 Apr 2002 - Successful preventive treatment of congenital heart block during pregnancy in a woman with systemic lupus erythematosus and anti-Sjögren's syndrome A/Ro antibody.
29 Sep 2005 - Anti-SS-A antibodies and fetal outcome in maternal systemic lupus erythematosus.
29 Sep 1986 - [Fetal complete heart block with myocarditis and maternal SS-A-/AA-B/antibodies]
15 Nov 1990 - Intravenous immunoglobulin in pregnancy: a chance for patients with an autoimmune disease.
29 Jun 2007
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.